SCHEMBL5609602

SCHEMBL5609602

CCOC(=O)C12CCN3CCCC3CCCCCCC/C=C/N1C2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.44
▸ LMNA P02545 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ POLB P06746 3/20 0.43
▸ PKM P14618 1/20 0.41
▸ KMT2A Q03164 7/20 0.37
▸ MEN1 O00255 5/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ NPY1R P25929 1/20 0.36
▸ MAPK1 P28482 3/20 0.35
▸ NPC1 O15118 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3370322 0.88 MMP1 (0.37) KDM4ELMNAMAPTPOLBPKM
SCHEMBL3814163 0.85 KDM4E (0.38) KDM4EPOLBKMT2AMEN1KCNH2
SCHEMBL4400728 0.69 KDM4E (0.39) KDM4ELMNAMAPTPOLBPKM
SCHEMBL597892 0.67 POLB (0.54) KDM4ELMNAMAPTPOLBPKM
SCHEMBL8863416 0.66 CHRM1 (0.54) KDM4ELMNAMAPTPOLBPKM
SCHEMBL3375177 0.65 MMP1 (0.38) KDM4EPOLBPKMKMT2AMEN1
SCHEMBL16098379 0.65 POLB (0.43) KDM4ELMNAMAPTPOLBPKM
SCHEMBL14964779 0.64 CHRM1 (0.61) KDM4ELMNAMAPTPOLBPKM
SCHEMBL14964771 0.63 CHRM1 (0.57) KDM4ELMNAMAPTPOLBPKM
SCHEMBL15910202 0.62 MAPK1 (0.44) KDM4ELMNAMAPTPOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1749007-A2 MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION Intermune, Inc. (US) 2007-02-07 — — EP disclosed
EP-1680137-A2 MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION Intermune, Inc. (US) 2006-07-19 — — EP disclosed
WO-2005095403-A2 MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION INTERMUNE, INC. (US) 2005-10-13 — — WO disclosed
WO-2005037214-A2 MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS INHIBITORS OF HCV REPLICATION INTERMUNE, INC. (US) 2005-04-28 — — WO disclosed
Send feedback